Abstract:Hematopoiesis is a tightly regulated process that produces all adult blood cells and immune cells from multipotent hematopoietic stem cells (HSCs). HSCs usually remain quiescent, and in the presence of external stimuli like infection or inflammation, they undergo division and differentiation as a compensatory mechanism. Normal hematopoiesis is impacted by systemic inflammation, which causes HSCs to transition from quiescence to emergency myelopoiesis. At the molecular level, inflammatory cytokine signaling molecules such as tumor necrosis factor (TNF), interferons, interleukins, and toll-like receptors can all cause HSCs to multiply directly. These cytokines actively encourage HSC activation, proliferation, and differentiation during inflammation, which results in the generation and activation of immune cells required to combat acute injury. The bone marrow niche provides numerous soluble and stromal cell signals, which are essential for maintaining normal homeostasis and output of the bone marrow cells. Inflammatory signals also impact this bone marrow microenvironment called the HSC niche to regulate the inflammatory-induced hematopoiesis. Continuous pro-inflammatory cytokine and chemokine activation can have detrimental effects on the hematopoietic system, which can lead to cancer development, HSC depletion, and bone marrow failure. Reactive oxygen species (ROS), which damage DNA and ultimately lead to the transformation of HSCs into cancerous cells, are produced due to chronic inflammation. The biological elements of the HSC niche produce pro-inflammatory cytokines that cause clonal growth and the development of leukemic stem cells (LSCs) in hematological malignancies. The processes underlying how inflammation affects hematological malignancies are still not fully understood. In this review, we emphasize the effects of inflammation on normal hematopoiesis, the part it plays in the development and progression of hematological malignancies, and potential therapeutic applications for targeting these pathways for therapy in hematological malignancies.

Inflammation in myelodysplastic syndrome pathogenesis

The Clinical Significance of Iron Overload and Iron Metabolism in Myelodysplastic Syndrome and Acute Myeloid Leukemia

Pathogenesis and inflammaging in myelodysplastic syndrome

Success in bone marrow failure? Novel therapeutic directions based on the immune environment of myelodysplastic syndromes

Somatic gene mutations expose cytoplasmic DNA to co-opt the cGAS/STING/NLRP3 axis in myelodysplastic syndromes

[Iron Overload and Immune Inflammatin Are Risk Factors for the Progression of Myelodysplastic Syndrome--Review]

The Molecular and Genetic Mechanisms of Inherited Bone Marrow Failure Syndromes: The Role of Inflammatory Cytokines in Their Pathogenesis

T cell dysfunctions in myelodysplastic syndromes

Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells

Inflammation as a driver of hematological malignancies

Innate immune pathways and inflammation in hematopoietic aging, clonal hematopoiesis, and MDS

The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia

The molecular pathogenesis of myelodysplastic syndromes

The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models?

Inflammatory Mesenchymal Stromal Cells and IFN-responsive T cells are key mediators of human bone marrow niche remodeling in CHIP and MDS

Immunotherapy in Myeloproliferative Diseases

Inflammatory recruitment of healthy hematopoietic stem and progenitor cells in the acute myeloid leukemia niche

Adaptive response to inflammation contributes to sustained myelopoiesis and confers a competitive advantage in myelodysplastic syndrome HSCs

Inflammation-related Genes S100s, RNASE3, and CYBB and Risk of Leukemic Transformation in Patients with Myelodysplastic Syndrome with Myelofibrosis.

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms

Biology of the Bone Marrow Microenvironment and Myelodysplastic Syndromes